Daunorubicin Hydrochloride
規格
23541-50-6CAS番号
245-723-4EC番号
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochlorideIUPAC名
C27H30ClNO10化学式
564 g/mol分子量
23541-50-6; DAUNORUBICIN HYDROCHLORIDE; DAUNORUBICIN HCL; Daunomycin hydrochloride; RP 13057 hydrochloride; Daunoblastina; Rubidomycin hydrochloride; Ondena; Daunomycin chlorohydrate; Daunomycin, hydrochloride; Daunoblastin; NDC 0082-4155; DTXSID0033382; RP-13057 Hydrochloride; Daunorubicin (as hydrochloride); UD984I04LZ; FI 6339 HYDROCHLORIDE; FI-6339 HYDROCHLORIDE; NSC-82151; DTXCID8013382; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride; NDC-0082-4155; Daunoblastine; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-; Rubilem; NSC82151; Daunorubicin.HCl; RefChem:54934; Cloridrato de Daunorubicina; Hydrochloride, Daunorubicin; Daunorubicini Hydrochloridum; (2S,4S)-2-Acetyl-4-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride; 245-723-4; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-; L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-,hydrochloride; NSC83142; Cerubidine; MFCD04974507; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; Rubomycin; Daunorubicin (Hydrochloride); FI 6339 [as the base]; DaunoXome; RP 13057 [as the base]; MLS000069508; RP 13057 [AS THE BASE); (8S,10S)-8-Acetyl-10-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride; CCRIS 915; C27H30ClNO10; MLS001336042; SMR000058559; EINECS 245-723-4; UNII-UD984I04LZ; Daunorubicin HCl (Daunomycin HCl); AI3-44887; SR-01000000033; SR-05000001600; Daunomycin HCL; Daunomycin; RP 13057; Rubidomycin; Daunomycin, HCl; Cerubidine (TN); SMR000768722; Daunorubicin hydrochloride [USAN:USP:JAN]; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride; SCHEMBL4444; CAS-23541-50-6; CHEMBL1563; (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride; MLS002222263; Daunorubicin hydrochloride CRS; orb1225564; orb1308388; SCHEMBL29354055; SCHEMBL29462666; CHEBI:31456; GLXC-06680; EX-A2649; Tox21_201159; CCG-39942; EBC-11147; HB4376; HY-13062R; MSK001345A-100M; s3035; Daunorubicin HCl - Bio-X trade mark; AKOS015920259; CS-1271; Daunorubicin hydrochloride (JP18/USP); DAUNORUBICIN HYDROCHLORIDE [MI]; KS-5149; MD11679; MSK001345A-1000M; Daunorubicin (hydrochloride) (Standard); DAUNORUBICIN HYDROCHLORIDE [JAN]; DAUNORUBICIN HYDROCHLORIDE [USAN]; NCGC00024246-03; NCGC00258711-01; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl))oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trhydroxy-1-methoxy-, hydrochloride, (8S,10S)-; BD164356; DAUNORUBICIN HYDROCHLORIDE [MART.]; DAUNORUBICIN HYDROCHLORIDE [VANDF]; HY-13062; SY058973; DAUNORUBICIN HYDROCHLORIDE [USP-RS]; DAUNORUBICIN HYDROCHLORIDE [WHO-DD]; Daunorubicin hydrochloride, >=90% (HPLC); NS00084572; ST51042193; D01264; DAUNORUBICIN HYDROCHLORIDE [ORANGE BOOK]; WP900 hydrochloride, >=95% (HPLC), solid; DAUNORUBICIN HYDROCHLORIDE [EP MONOGRAPH]; DAUNORUBICIN HYDROCHLORIDE [USP IMPURITY]; DAUNORUBICIN HYDROCHLORIDE [USP MONOGRAPH]; SR-01000000033-6; SR-05000001600-3; Q27291034; Daunorubicin hydrochloride, meets USP testing specifications; Daunorubicine hydrochloride Solution in Methanol, 1000ug/mL; Daunorubicine hydrochloride Solution in Methanol, 100ug/mL; Daunorubicin Hydrochloride; RP 13057 Hydrochloride; Daunomycin; Daunorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard; Daunorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard; (1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE HYDROCHLORIDE; (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside--hydrogen chloride (1/1); (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyransoyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-I<<-L-lyxo-hexopyransoyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride; 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL))OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S-CIS)-, HYDROCHLORIDE; 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 5,12-Naphthacenedione,8-acetyl-10-[(3-aMino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-,hydrChemicalbookochloride(1:1),(8S,10S)-; 8S-acetyl-10S-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, monohydrochloride別名
Daunorubicin Hydrochlorideを含む製品
다우노신주20밀리그램(다우노루비신염산염)빅시오스리포좀주주사용다우노마이신20밀리그램(다우노루비신염산염)(수출용)다우노신주(다우노루비신염산염)(수출용)ビキセオス配合静注用VYXEOS LIPOSOMAL 44 MG/100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONDAUNOBLASTINA 20 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEVYXEOS LIPOSOMAL 44 mg/100 mg, poudre pour solution à diluer pour perfusionCERUBIDINE 20 mg, poudre pour solution pour perfusionDaunorubicin Hcl - Sicor Societa Italiana Corticosteroidi SrlDaunorubicin Hcl - Zhejiang Hisun PharmaceuticalDaunorubicin Hcl - TAPI Technology & API Services
1/2ページ
Daunorubicin Hydrochlorideを販売する企業
한국
한국유나이티드제약(주)Republic of Korea동아
동아에스티(주)Republic of KoreaHD
Hangzhou Dingyan Chem Co., LtdChinaZH
Zhejiang Hisun Chemical Co., Ltd.China1/2ページ